⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3478880 | 1.00 | — | — | |
| SCHEMBL20342123 | 1.00 | — | — | |
| SCHEMBL28176953 | 0.80 | — | — | |
| SCHEMBL18869797 | 0.78 | LMNA (0.37) | — | |
| SCHEMBL24163835 | 0.77 | ATM (0.41) | — | |
| SCHEMBL13789969 | 0.74 | — | — | |
| SCHEMBL10266427 | 0.74 | — | — | |
| SCHEMBL12247762 | 0.74 | — | — | |
| SCHEMBL28091576 | 0.74 | — | — | |
| SCHEMBL26207631 | 0.74 | ATM (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371362-B2 | Prostate specific antigen agents and methods of using same for prostate cancer imaging | VISEN MEDICAL, INC. (US) | 2016-06-21 | — | — | US | disclosed |
| WO-2015058868-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | PANGAEA BIOTECH, S.L. (ES) | 2015-04-30 | — | — | WO | disclosed |
| US-20140050662-A1 | PROSTATE SPECIFIC ANTIGEN AGENTS AND METHODS OF USING SAME FOR PROSTATE CANCER IMAGING | VISEN MEDICAL, INC. | 2014-02-20 | — | — | US | disclosed |
| EP-0854140-B1 | Vitronectin receptor antagonists, their production and their use | SANOFI AVENTIS DEUTSCHLAND (DE) | 2013-11-06 | — | — | EP | disclosed |
| EP-1570835-B1 | Composition for the permanent deformation of the hair comprising at least one carboxydithiol | OREAL (FR) | 2010-10-20 | — | — | EP | disclosed |